Opus Genetics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio4.11
Forward P/E14.07
P/S Ratio3.423.581.84109.56
P/B Ratio1.471.361.592.90-5.22
Price/Tangible Book5.591.361.592.90
Price/FCF5.13
Price/OCF5.13
Enterprise Value Ratios
EV/Revenue0.091.351.4971.13
EV/EBITDA3.26
EV/EBIT3.26
EV/FCF4.16
Profitability & Returns
Return on Equity (ROE)-1.52%-0.21%0.52%-12.95%
Return on Assets (ROA)-0.47%-0.13%0.30%-0.65%-0.61%
Return on Invested Capital (ROIC)-7.17%22.92%
Return on Capital Employed (ROCE)-1.33%-0.21%0.39%-1.02%-0.65%
Leverage & Solvency Ratios
Debt/Equity0.02
Liquidity Ratios
Current Ratio3.2413.3517.796.765.55
Quick Ratio3.2013.0717.276.425.15
Efficiency Ratios
Asset Turnover0.240.371.060.03
Yield & Distribution Ratios
Earnings Yield-1.53%-0.15%0.24%-0.88%-0.35%
FCF Yield-0.68%-0.02%0.19%-0.30%-0.12%
Buyback Yield-0.24%-0.05%-0.39%-2.19%-0.64%